Immunoplus tablets 100 mg. №20

Description

Immunoplus Storage
active substance: 1 tablet contains Echinacea purpurea L. squeezed juice dry 100 mg;

Excipients: sorbitol (E 420), colloidal anhydrous silica, magnesium stearate.

Immunoplus Dosage form
Tablets.

Main physical and chemical properties: round tablets with a biconvex surface from pale yellow-brown to brown with patches.

Immunoplus Pharmacotherapeutic group
Immunostimulants. ATX code L03A X.

Pharmacological properties

Pharmacodynamics.

Plant biogenic stimulator, which has immunomodulatory and anti-inflammatory effects, stimulates bone marrow hematopoiesis, resulting in an increase in the number of leukocytes and cells of the reticuloendothelial system of the spleen. It activates mainly cellular immunity, stimulates the phagocytic activity of macrophages and chemotaxis of granulocytes, promotes the release of cytokines, increases the production of interleukin-1 by macrophages, accelerates the transformation of B-lymphocytes into plasma cells, enhances antibody activity and T-activity. Increases non-specific resistance of the body (including to pathogens of influenza and herpes).

Pharmacokinetics.

It is well absorbed in the digestive tract. Excreted in urine and feces.

Indication
As a part of combination therapy at frequent recurrences of infectious diseases of respiratory and urinary tracts.

At the first signs of SARS, long-term use of antibiotics.

Contraindication
Hypersensitivity to plants of the family Compositae (chamomile, arnica, calendula, dandelion) or to any other component of the drug.

Progressive systemic disorders (tuberculosis, sarcoidosis); diseases of the hematopoietic system (leukemia, leukemia, agranulocytosis); autoimmune diseases, including multiple sclerosis, collagenosis, systemic lupus erythematosus; chronic viral diseases; oncological diseases; AIDS or HIV infection; immunosuppression or immunodeficiency of various etiologies; diabetes; rheumatism.

Children under 12 years. Pregnancy or breastfeeding.

Interaction with other medicinal products 
Due to the immunostimulatory effect of echinacea may reduce the effectiveness of drugs that have an immunosuppressive effect.

The drug is not recommended to be used concomitantly with drugs with hepatotoxic effects, such as amiodarone, methotrexate, ketaconazole, steroid drugs.

Enhancement or attenuation of the effect is not excluded with the concomitant use of drugs, the elimination of which depends on the activity of cytochrome P450, isomers of CYP3A or CYP1A2.